4//SEC Filing
SUNESIS PHARMACEUTICALS INC 4
Accession 0001179110-14-004414
$VIRXCIK 0001061027operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:52 PM ET
Size
8.2 KB
Accession
0001179110-14-004414
Insider Transaction Report
Form 4
DePinto Joseph I
EVP, CCO
Transactions
- Award
Stock Option (Right to Buy)
2014-02-28+50,000→ 50,000 totalExercise: $6.55Exp: 2024-02-27→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2014-02-28+250,000→ 250,000 totalExercise: $6.55Exp: 2024-02-27→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to this stock option shall vest on the one (1) year anniversary of the vesting commencement date; thereafter one forty-eighth (1/48th) of the shares shall vest over the following thirty-six (36) months, provided, that at each such vesting date,the reporting person shall then be providing service (as defined in the Option Plan) to the Company.
- [F2]One hundred percent (100%) of the shares subject to this stock option shall vest upon the earlier of (i) the ten year anniversary of the date of grant of such stock option, and (ii) the date the reporting person and the reporting person's immedicate family relocate and change their domicile to the San Francisco Bay Area, provided, that at each such vesting date,the reporting person shall then be providing service (as defined in the Option Plan) to the Company.
Documents
Issuer
SUNESIS PHARMACEUTICALS INC
CIK 0001061027
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001061027
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:52 PM ET
- Size
- 8.2 KB